Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues - PubMed (original) (raw)
Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues
A Virkamäki et al. Endocrinology. 1997 Jun.
Abstract
We determined the effect of infusion of glucosamine (GlcN), which bypasses the rate limiting reaction in the hexosamine pathway, on insulin-stimulated rates of glucose uptake and glycogen synthesis in vivo in rat tissues varying with respect to their glutamine:fructose-6-phosphate amidotransferase (GFA) activity. Three groups of conscious fasted rats received 6-h infusions of either saline (BAS), insulin (18 mU/kg x min) and saline (INS), or insulin and GlcN (30 micromol/ kg x min, GLCN). [3-(3)H]glucose was infused to trace whole body glucose kinetics and glycogen synthesis, and rates of tissue glucose uptake were determined using a bolus injection of [1-(14)C]2-deoxyglucose at 315 min. GlcN decreased insulin-stimulated glucose uptake (315-360 min) by 49% (P < 0.001) at the level of the whole body, and by 31-53% (P < 0.05 or less) in the heart, epididymal fat, submandibular gland and in soleus, abdominis and gastrocnemius muscles. GlcN completely abolished glycogen synthesis in the liver. GlcN decreased insulin-stimulated glucose uptake similarly in the submandibular gland (1.3 +/- 0.2 vs. 2.0 +/- 0.3 nmol/mg protein x min, GLCN vs. INS, P < 0.05) and gastrocnemius muscle (1.4 +/- 0.3 vs. 3.1 +/- 0.5 nmol/mg protein x min), although the activity of the hexosamine pathway, as judged from basal GFA activity, was 10-fold higher in the submandibular gland (286 +/- 35 pmol/mg protein x min) than in gastrocnemius muscle (27 +/- 3 pmol/mg protein x min, P < 0.001). These data raise the possibility that overactivity of the hexosamine pathway may contribute to glucose toxicity not only in skeletal muscle but also in other insulin sensitive tissues. They also imply that the magnitude of insulin resistance induced between tissues is determined by factors other than GFA.
Similar articles
- Increased hexosamine availability similarly impairs the action of insulin and IGF-1 on glucose disposal.
Hawkins M, Barzilai N, Chen W, Angelov I, Hu M, Cohen P, Rossetti L. Hawkins M, et al. Diabetes. 1996 Dec;45(12):1734-43. doi: 10.2337/diab.45.12.1734. Diabetes. 1996. PMID: 8922359 - Insulin and glucosamine infusions increase O-linked N-acetyl-glucosamine in skeletal muscle proteins in vivo.
Yki-Järvinen H, Virkamäki A, Daniels MC, McClain D, Gottschalk WK. Yki-Järvinen H, et al. Metabolism. 1998 Apr;47(4):449-55. doi: 10.1016/s0026-0495(98)90058-0. Metabolism. 1998. PMID: 9550544 - Role of the glucosamine pathway in fat-induced insulin resistance.
Hawkins M, Barzilai N, Liu R, Hu M, Chen W, Rossetti L. Hawkins M, et al. J Clin Invest. 1997 May 1;99(9):2173-82. doi: 10.1172/JCI119390. J Clin Invest. 1997. PMID: 9151789 Free PMC article. - Hexosamines and insulin resistance.
McClain DA, Crook ED. McClain DA, et al. Diabetes. 1996 Aug;45(8):1003-9. doi: 10.2337/diab.45.8.1003. Diabetes. 1996. PMID: 8690144 Review. - Hexosamines, insulin resistance, and the complications of diabetes: current status.
Buse MG. Buse MG. Am J Physiol Endocrinol Metab. 2006 Jan;290(1):E1-E8. doi: 10.1152/ajpendo.00329.2005. Am J Physiol Endocrinol Metab. 2006. PMID: 16339923 Free PMC article. Review.
Cited by
- Dissecting PUGNAc-mediated inhibition of the pro-survival action of insulin.
Teo CF, El-Karim EG, Wells L. Teo CF, et al. Glycobiology. 2016 Nov;26(11):1198-1208. doi: 10.1093/glycob/cww043. Epub 2016 Apr 12. Glycobiology. 2016. PMID: 27072814 Free PMC article. - Non-NSAID over-the-counter (OTC) remedies for arthritis: good, bad or indifferent?
Whitehouse MW, Butters DE. Whitehouse MW, et al. Inflammopharmacology. 1999;7(3):227-47. doi: 10.1007/s10787-999-0006-z. Inflammopharmacology. 1999. PMID: 17638094 - Acute glucosamine-induced insulin resistance in muscle in vivo is associated with impaired capillary recruitment.
Wallis MG, Smith ME, Kolka CM, Zhang L, Richards SM, Rattigan S, Clark MG. Wallis MG, et al. Diabetologia. 2005 Oct;48(10):2131-9. doi: 10.1007/s00125-005-1887-z. Epub 2005 Jul 30. Diabetologia. 2005. PMID: 16059714 - Hexosamine flux, the O-GlcNAc modification, and the development of insulin resistance in adipocytes.
Teo CF, Wollaston-Hayden EE, Wells L. Teo CF, et al. Mol Cell Endocrinol. 2010 Apr 29;318(1-2):44-53. doi: 10.1016/j.mce.2009.09.022. Epub 2009 Sep 30. Mol Cell Endocrinol. 2010. PMID: 19799964 Free PMC article. Review. - Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance.
Virkamäki A, Ueki K, Kahn CR. Virkamäki A, et al. J Clin Invest. 1999 Apr;103(7):931-43. doi: 10.1172/JCI6609. J Clin Invest. 1999. PMID: 10194465 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials